HUP0104937A2 - Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandja - Google Patents
Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandjaInfo
- Publication number
- HUP0104937A2 HUP0104937A2 HU0104937A HUP0104937A HUP0104937A2 HU P0104937 A2 HUP0104937 A2 HU P0104937A2 HU 0104937 A HU0104937 A HU 0104937A HU P0104937 A HUP0104937 A HU P0104937A HU P0104937 A2 HUP0104937 A2 HU P0104937A2
- Authority
- HU
- Hungary
- Prior art keywords
- receptor
- receptor protein
- protein
- ligands
- proteins
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 7
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 2
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 2
- 102000005962 receptors Human genes 0.000 abstract 10
- 108020003175 receptors Proteins 0.000 abstract 10
- 150000001875 compounds Chemical class 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000012216 screening Methods 0.000 abstract 3
- 108091006027 G proteins Proteins 0.000 abstract 2
- 102000030782 GTP binding Human genes 0.000 abstract 2
- 108091000058 GTP-Binding Proteins 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 206010012335 Dependence Diseases 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000001638 cerebellum Anatomy 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30594998 | 1998-10-27 | ||
| JP2771099 | 1999-02-04 | ||
| JP5720799 | 1999-03-04 | ||
| JP27622599A JP4486187B2 (ja) | 1998-10-27 | 1999-09-29 | 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド |
| PCT/JP1999/005905 WO2000024890A1 (en) | 1998-10-27 | 1999-10-26 | Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0104937A2 true HUP0104937A2 (hu) | 2002-04-29 |
Family
ID=27458743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104937A HUP0104937A2 (hu) | 1998-10-27 | 1999-10-26 | Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandja |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6699965B1 (enExample) |
| EP (1) | EP1126028B1 (enExample) |
| JP (1) | JP4486187B2 (enExample) |
| KR (1) | KR20010085974A (enExample) |
| CN (1) | CN1324405A (enExample) |
| AT (1) | ATE394485T1 (enExample) |
| AU (1) | AU6230699A (enExample) |
| BR (1) | BR9914835A (enExample) |
| CA (1) | CA2347294A1 (enExample) |
| CZ (1) | CZ20011358A3 (enExample) |
| DE (1) | DE69938666D1 (enExample) |
| HU (1) | HUP0104937A2 (enExample) |
| ID (1) | ID28288A (enExample) |
| IL (1) | IL142428A0 (enExample) |
| NO (1) | NO20012059L (enExample) |
| NZ (1) | NZ510977A (enExample) |
| PL (1) | PL347553A1 (enExample) |
| SK (1) | SK5502001A3 (enExample) |
| WO (1) | WO2000024890A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2364988A1 (en) * | 1999-02-24 | 2000-08-31 | Merck & Co., Inc. | G protein-coupled receptor resembling galanin receptors |
| CA2404257A1 (en) * | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Novel protein, dna thereof and process for producing the same |
| EP1168259A3 (en) | 2000-06-28 | 2003-12-17 | Hitachi, Ltd. | Data management method and system for IC card |
| JP4762481B2 (ja) * | 2000-08-30 | 2011-08-31 | 株式会社セルフリーサイエンス | 無細胞タンパク質合成用転写鋳型の設計および構築、並びにこれを用いる希釈バッチ方式コムギ胚芽無細胞タンパク質合成法 |
| JP2002109169A (ja) | 2000-09-29 | 2002-04-12 | Hitachi Ltd | 作業支援方法並びにシステム及び作業支援方法を記録した記録媒体 |
| EP1346722B1 (en) | 2000-12-01 | 2008-12-10 | Takeda Pharmaceutical Company Limited | Method for producing preparation containing bioactive substance |
| EP1363655A4 (en) * | 2000-12-18 | 2005-04-06 | Merck & Co Inc | FOR A G-PROTEIN-COUPLED RECEPTOR - GPR 54 - FROM HUMAN AND MOUSE-CODING, ISOLATED NUCLEIC ACID MOLECULES, PROTEINS CODED THEREBY, TRANSFORMED CELLS THEREOF, AND USES THEREOF |
| WO2002057309A1 (fr) * | 2001-01-18 | 2002-07-25 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice couplee a la proteine g et adn de cette proteine |
| WO2002072816A1 (fr) * | 2001-02-26 | 2002-09-19 | Takeda Chemical Industries, Ltd. | Proteine de recepteur murin de type kiss-1 et adn correspondant |
| WO2002083735A1 (fr) * | 2001-04-06 | 2002-10-24 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice et son adn |
| AU2008202004A1 (en) * | 2001-09-18 | 2008-05-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| ES2431929T3 (es) * | 2001-09-18 | 2013-11-28 | Genentech, Inc. | Composiciones y procedimientos para el diagnóstico y el tratamiento de tumores |
| ATE360034T1 (de) * | 2001-09-19 | 2007-05-15 | Takeda Pharmaceutical | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft |
| EP1466976A4 (en) * | 2002-01-11 | 2005-11-09 | Takeda Pharmaceutical | PROCESS FOR PREPARING KISS-1 PEPTIDES |
| WO2004024072A2 (en) * | 2002-09-11 | 2004-03-25 | Genentech, Inc. | Novel compositions and methods for the treatment of immune related diseases |
| AU2003292696A1 (en) | 2002-12-26 | 2004-08-10 | Takeda Pharmaceutical Company Limited | Metastin derivative and use thereof |
| US6800611B2 (en) * | 2003-01-06 | 2004-10-05 | Takeda Chemical Industries, Ltd. | Metastin derivatives and their use |
| EP1604682A4 (en) * | 2003-03-12 | 2009-06-24 | Takeda Chemical Industries Ltd | AGENTS IMPROVING GONADIC FUNCTION |
| JP4639052B2 (ja) * | 2003-03-12 | 2011-02-23 | 武田薬品工業株式会社 | 性腺機能改善剤 |
| EP1464652A1 (en) * | 2003-04-02 | 2004-10-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases |
| CA2523600A1 (en) * | 2003-04-28 | 2004-11-11 | Wyeth | Methods utilising g-protein coupled receptor 54 |
| WO2004101747A2 (en) * | 2003-05-07 | 2004-11-25 | The General Hospital Corporation | Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| WO2005040833A1 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Regulation of human metastin recognising receptors |
| MXPA06014206A (es) | 2004-06-25 | 2007-02-14 | Takeda Pharmaceutical | Derivados de metastina y uso de los mismos. |
| US20090099334A1 (en) * | 2005-12-22 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| TWI386417B (zh) | 2005-12-22 | 2013-02-21 | Takeda Pharmaceutical | 轉移抑素衍生物及其用途 |
| ITMI20061607A1 (it) | 2006-08-09 | 2008-02-10 | Maria Vincenza Carriero | Peptidi con attivita farmacologica |
| TWI404726B (zh) | 2006-10-25 | 2013-08-11 | Takeda Pharmaceutical | 腫瘤轉移抑制素衍生物及其用途 |
| EP2277900A4 (en) * | 2008-04-24 | 2011-08-03 | Takeda Pharmaceutical | METASTINE DERIVATIVE AND ITS USE |
| US20110212890A1 (en) | 2008-07-30 | 2011-09-01 | Takeda Pharmaceutical Company Limited | Metastin derivative and use thereof |
| EP2898900B1 (en) | 2008-09-19 | 2017-11-15 | Nektar Therapeutics | Polymer conjugates of ziconotide |
| EP2340047A1 (en) * | 2008-09-19 | 2011-07-06 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
| US8716228B2 (en) | 2009-05-27 | 2014-05-06 | Yeda Research And Development Co. Ltd. | GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities |
| JP6224586B2 (ja) | 2012-07-10 | 2017-11-01 | 武田薬品工業株式会社 | 注射用製剤 |
| CN109206481B (zh) | 2017-07-05 | 2023-08-18 | 尚华医药科技(江西)有限公司 | 一种肽类化合物、其应用及含其的组合物 |
| CN109212217B (zh) * | 2018-11-07 | 2021-09-10 | 李玉民 | 基于amy1a蛋白胃癌检测试剂盒及其使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436155A (en) * | 1991-12-31 | 1995-07-25 | Arch Development Corporation | Isolated DNA encoding a somatostatin receptor |
| AU4426296A (en) | 1994-08-11 | 1996-03-07 | Takeda Chemical Industries Ltd. | G protein coupled receptor protein, production, and use thereof |
| WO1997013778A1 (en) | 1995-10-11 | 1997-04-17 | The Penn State Research Foundation | A metastasis suppressor gene |
| US6010877A (en) * | 1997-01-10 | 2000-01-04 | Smithkline Beecham Corporation | cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| US5851798A (en) * | 1997-01-27 | 1998-12-22 | Smithkline Beecham Corporation | Nucleic acid encoding human GPR14 receptor |
| CA2283299A1 (en) | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| US6420526B1 (en) * | 1997-03-07 | 2002-07-16 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| CA2364988A1 (en) | 1999-02-24 | 2000-08-31 | Merck & Co., Inc. | G protein-coupled receptor resembling galanin receptors |
| US20020077469A1 (en) * | 1999-03-10 | 2002-06-20 | Borowsky Beth E. | DNA encoding orphan SNORF11 receptor |
| EP1604682A4 (en) * | 2003-03-12 | 2009-06-24 | Takeda Chemical Industries Ltd | AGENTS IMPROVING GONADIC FUNCTION |
-
1999
- 1999-09-29 JP JP27622599A patent/JP4486187B2/ja not_active Expired - Fee Related
- 1999-10-26 IL IL14242899A patent/IL142428A0/xx unknown
- 1999-10-26 HU HU0104937A patent/HUP0104937A2/hu unknown
- 1999-10-26 DE DE69938666T patent/DE69938666D1/de not_active Expired - Lifetime
- 1999-10-26 CA CA002347294A patent/CA2347294A1/en not_active Abandoned
- 1999-10-26 SK SK550-2001A patent/SK5502001A3/sk unknown
- 1999-10-26 AU AU62306/99A patent/AU6230699A/en not_active Abandoned
- 1999-10-26 CN CN99812722A patent/CN1324405A/zh active Pending
- 1999-10-26 KR KR1020017005344A patent/KR20010085974A/ko not_active Withdrawn
- 1999-10-26 US US09/830,428 patent/US6699965B1/en not_active Expired - Fee Related
- 1999-10-26 AT AT99949421T patent/ATE394485T1/de not_active IP Right Cessation
- 1999-10-26 NZ NZ510977A patent/NZ510977A/xx unknown
- 1999-10-26 WO PCT/JP1999/005905 patent/WO2000024890A1/ja not_active Ceased
- 1999-10-26 CZ CZ20011358A patent/CZ20011358A3/cs unknown
- 1999-10-26 EP EP99949421A patent/EP1126028B1/en not_active Expired - Lifetime
- 1999-10-26 PL PL99347553A patent/PL347553A1/xx not_active Application Discontinuation
- 1999-10-26 BR BR9914835-8A patent/BR9914835A/pt not_active IP Right Cessation
- 1999-10-27 ID IDW20010936A patent/ID28288A/id unknown
-
2001
- 2001-04-26 NO NO20012059A patent/NO20012059L/no not_active Application Discontinuation
-
2004
- 2004-02-05 US US10/771,417 patent/US7314754B2/en not_active Expired - Fee Related
-
2007
- 2007-10-24 US US11/976,414 patent/US7608409B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000024890A1 (en) | 2000-05-04 |
| NO20012059L (no) | 2001-06-26 |
| ATE394485T1 (de) | 2008-05-15 |
| AU6230699A (en) | 2000-05-15 |
| DE69938666D1 (de) | 2008-06-19 |
| US7314754B2 (en) | 2008-01-01 |
| EP1126028B1 (en) | 2008-05-07 |
| US7608409B2 (en) | 2009-10-27 |
| US20080131976A1 (en) | 2008-06-05 |
| BR9914835A (pt) | 2002-06-18 |
| US6699965B1 (en) | 2004-03-02 |
| IL142428A0 (en) | 2002-03-10 |
| CA2347294A1 (en) | 2000-05-04 |
| SK5502001A3 (en) | 2002-01-07 |
| KR20010085974A (ko) | 2001-09-07 |
| CN1324405A (zh) | 2001-11-28 |
| JP4486187B2 (ja) | 2010-06-23 |
| CZ20011358A3 (cs) | 2001-08-15 |
| ID28288A (id) | 2001-05-10 |
| US20040180407A1 (en) | 2004-09-16 |
| EP1126028A4 (en) | 2002-11-27 |
| PL347553A1 (en) | 2002-04-08 |
| JP2000312590A (ja) | 2000-11-14 |
| NO20012059D0 (no) | 2001-04-26 |
| NZ510977A (en) | 2002-10-25 |
| EP1126028A1 (en) | 2001-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69637473T2 (de) | An einem thrombopoietin rezeptor bindende peptide und zusammensetzungen | |
| Lee et al. | Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. | |
| Yang et al. | Human group-specific component (Gc) is a member of the albumin family. | |
| IL142428A0 (en) | Novel g protein-couple receptor proteins, dna's thereof and ligands to the same | |
| Himmler et al. | Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein | |
| US7999069B2 (en) | EphB receptor-binding peptides | |
| US6555111B2 (en) | Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodies | |
| ATE253111T1 (de) | Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung | |
| DE60123998T2 (de) | Lösliche zcyctor 11 cytokinrezeptoren | |
| JP2010513506A5 (enExample) | ||
| JPH09504030A (ja) | Ｃｎｔｆ族アンタゴニスト | |
| DE69326759T2 (de) | Lymphozytenaktivierungsantigen hb15 ein mitglied der immunglobulin superfamilie | |
| Coulthard et al. | Characterization of the Epha1 receptor tyrosine kinase: expression in epithelial tissues | |
| JPH07506486A (ja) | 免疫グロブリンＥの高アフィニティレセプタのヒトβサブユニットの分離，特性化および用法 | |
| CA2064814C (en) | Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof | |
| JP4208960B2 (ja) | オピオイドレセプター遺伝子 | |
| DE965041T1 (de) | Methode zum identifizieren von modulatoren der zelloberflächenmembranrezeptoren,nützlich zur behandlung von krankheiten | |
| EP1257822A4 (en) | HER-2 BINDING ANTAGONISTS | |
| ATE364627T1 (de) | G-protein gekoppelter rezeptor mit vergrösserter, extrazellulärer domäne | |
| Cullen et al. | Sequence requirements for ligand binding and cell surface expression of the Tac antigen, a human interleukin-2 receptor. | |
| Anderson et al. | Beta adrenoreceptors in the rabbit bladder detrusor muscle. | |
| DE60109412T2 (de) | Therapeutische peptide | |
| DE69735424T2 (de) | Verfahren und mittel zur modifikation der komplementaktivierungskaskade | |
| WO2002007676A3 (en) | Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr) | |
| US20040241757A1 (en) | Novel screening method using prokineticin receptor |